- Home
- PBYI vs PZC Comparison
PBYI vs PZC Comparison
Compare PBYI & PZC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- PZC
- Stock Information
- Founded
- PBYI 2010
- PZC 2002
- Country
- PBYI United States
- PZC United States
- Employees
- PBYI N/A
- PZC N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- PZC Investment Managers
- Sector
- PBYI Health Care
- PZC Finance
- Exchange
- PBYI Nasdaq
- PZC Nasdaq
- Market Cap
- PBYI 145.3M
- PZC 150.3M
- IPO Year
- PBYI N/A
- PZC N/A
- Fundamental
- Price
- PBYI $2.91
- PZC $6.86
- Analyst Decision
- PBYI Strong Buy
- PZC
- Analyst Count
- PBYI 1
- PZC 0
- Target Price
- PBYI $7.00
- PZC N/A
- AVG Volume (30 Days)
- PBYI 288.9K
- PZC 48.2K
- Earning Date
- PBYI 02-27-2025
- PZC 01-01-0001
- Dividend Yield
- PBYI N/A
- PZC 4.68%
- EPS Growth
- PBYI 492.79
- PZC N/A
- EPS
- PBYI 0.47
- PZC N/A
- Revenue
- PBYI $243,569,000.00
- PZC N/A
- Revenue This Year
- PBYI N/A
- PZC N/A
- Revenue Next Year
- PBYI N/A
- PZC N/A
- P/E Ratio
- PBYI $6.24
- PZC N/A
- Revenue Growth
- PBYI 6.30
- PZC N/A
- 52 Week Low
- PBYI $2.23
- PZC $6.30
- 52 Week High
- PBYI $7.15
- PZC $8.20
- Technical
- Relative Strength Index (RSI)
- PBYI 48.76
- PZC 56.75
- Support Level
- PBYI $2.69
- PZC $6.77
- Resistance Level
- PBYI $2.98
- PZC $6.79
- Average True Range (ATR)
- PBYI 0.12
- PZC 0.06
- MACD
- PBYI 0.01
- PZC 0.01
- Stochastic Oscillator
- PBYI 58.11
- PZC 80.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About PZC PIMCO California Municipal Income Fund III of Beneficial Interest
PIMCO CA Muni Income Fund III operates as a closed-end management investment company. The investment objective of the fund is to seek to provide current income exempt from federal and California income tax. Its portfolio of investments includes investment in different sectors such as education, healthcare, industrial and others.